section name header

Evidence summaries

Metformin Combined with Gonadotrophins during Ovulation Induction for Subfertility in Polycystic Ovary Syndrome

Metformin combined with gonadotrophins may increase live birth rate among women with polycystic ovary syndrome (PCOS) undergoing ovulation induction compared with gonadotrophins alone. Level of evidence: "C"

The quality of evidence is downgraded by study limitations (unclear allocation concelament and lack blinding in half of the studies) and by imprecise results (few patients and outcome events).

Summary

A Cochrane review [Abstract] 1 included 5 studies with a total of 264 subjects comparing gonadotrophins plus metformin versus gonadotrophins in anovulation due to polycystic ovary syndrome (PCOS). The gonadotrophin used was recombinant follicle stimulationg hormone (FSH) in 4 studies and highly purified FSH in 1 study. Metformin plus FSH was associated with a higher live birth rate when compared with FSH (table T1). This suggests that if the chance of live birth after FSH is assumed to be 27%, then the chance after addition of metformin would be between 32% and 60%. There were no difference in rates of multiple pregnancy, miscarriage, or ovarian hyperstimulation syndrome.

Gonadotrophins plus metformin versus gonadotrophins for subfertility

OutcomeRelative effect (95% CI) ORAssumed risk - Gonadotrophins plus placeboIntervention - Gonadotrophins plus metforminNumber of participants (studies)
Live birth rate Follow-up: 3-6 months2.31 (1.24 to 4.33)267 per 1000457 per 1000,190 more per 1000 (42 to 345)180 (2)
Multiple pregnancy rate0.55(0.15 to 1.95)52 per 100026 per 1000,23 fewer per 1000 (44 fewer to 25 more)232 (4)
Ongoing pregnancy rate2.46 (1.36 to 4.46)217 per 1000393 per 1000,189 more per 1000 (57 to 336)232 (4)
Clinical pregnancy rate2.51 (1.46 to 4.31)252 per 1000444 per 1000,206 more per 1000 (78 to 340)264 (5)

Clinical comments

Note

Date of latest search: 2018-06-04

References

  • Bordewijk EM, Nahuis M, Costello MF et al. Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2017;(1):CD009090. [PubMed]

Primary/Secondary Keywords